Equillium vs Nektar Therapeutics
EQ and NKTR side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EQ and NKTR compare
Nektar Therapeutics is the larger company, worth 16 times as much as Equillium ($1.3B against $81.8M).
Nektar Therapeutics scores higher on the StockData Score (9 against 8 for Equillium), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EQ | NKTR |
|---|---|---|
| Size and price | ||
| Market cap | $81.8M | $1.3B |
| Share price | $1.29 | $37.27 |
| Change, 1 year | 39.6% | −35.4% |
| Change, 5 years | −75.4% | −78.9% |
| Beta (5Y) | 0.42 | 2.06 |
| Employees | 14 | 63 |
| StockData Score | ||
| Total score | 8 | 9 (better) |
| Valuation score | 1 | 1 |
| Growth score | 0 | 1 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 6 (better) | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 23.0× |
| P/B | 1.6× | 1.5× (better) |
| FCF yield | −18.9% | −16.4% (better) |
| Growth | ||
| Revenue growth (TTM) | – | −43.9% |
| Revenue growth, 5Y average | – | −18.4% |
| Profitability | ||
| Gross margin | – | 100% |
| Operating margin | – | −254% |
| Net margin | – | −297% |
| FCF margin | – | −378% |
| Return on equity | −43.9% | −35.1% (better) |
| Return on invested capital | – | −441% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 19.49 (better) | 9.00 |
| Altman Z-score | 9.83 (better) | −0.89 |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Buyback yield | – | 0.00% |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 65.8% | 105% |
| Held by insiders | 7.6% | 0.46% |
| Insider net buying, 12 months | −$2.7M | −$2.2M (better) |
| Short interest, % of float | 10.1% | 19.9% |
Go deeper
- EQ stock overview
- EQ income statement
- EQ valuation and score
- NKTR stock overview
- NKTR income statement
- NKTR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.